This version of the registration was submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020. Due to different information requirements at that time, the registration is presented in the following format.
Registration ID: 519335
Submitted by lobbyist on: December 7, 2015 09:46:04 AM
Accepted by Registrar on: January 6, 2016 11:23:09 AM
Designated Filer Information
| Crawley, Tami Lynn |
| 4590 Windsor Street | |
|
Vancouver, BC, V5V 4P7
|
778-233-9785 |
| Canada |
Organization Information
| Bristol-Myers Squibb Canada |
| Pharmaceutical Manufacturer |
| 4590 Windsor Street | |
|
Vancouver, BC, V5V 4P7
|
778-233-9785 |
| Canada |
Relevant Affiliates
The client has no relevant affiliates.
Government or Government Agency Funding
The organization does not receive any funding from a government or government agency.
Other Controlling or Directing Interests
The organization has no other controlling or directing interests.
Active Registration Period
| December 7, 2015 | |
| June 4, 2016 |
Organization's In-House Lobbyists
|
|||||
|
|
BC Public Office Background
This individual has not held any public office positions in BC.
Lobbying Activities
Health
Awarding, amendment or termination of a contract, grant or financial benefit
MBPSD does not purchase BMS pharmaceuticals, but it does cover the cost for eligiable residents of BC. BMS works with MBPSD to activate listings that have been approved by CADTH and the Pan Canadian Pharmaceutical Alliance. BMS reimburses
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Public Agency | Health | December 7, 2015 |